KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 104,762 Value ($000) $2,067 Avg Close — Range —
Q4 2023
Shares 85,416 Value ($000) $1,498 Avg Close — Range —
Q3 2023
Shares 62,814 Value ($000) $1,091 Avg Close — Range —
Q2 2023
Shares 44,643 Value ($000) $629 Avg Close — Range —
Q1 2023
Shares 51,315 Value ($000) $552 Avg Close — Range —
Q4 2022
Shares 57,105 Value ($000) $855 Avg Close — Range —
Q1 2022
Shares 1,173 Value ($000) $12 Avg Close — Range —
Q4 2021
Shares 76,475 Value ($000) $900 Avg Close — Range —
Q3 2021
Shares 82,737 Value ($000) $942 Avg Close — Range —
Q2 2021
Shares 20,019 Value ($000) $279 Avg Close — Range —
Q1 2021
Shares 35,643 Value ($000) $660 Avg Close — Range —
Q4 2020
Shares 1,367 Value ($000) $24 Avg Close — Range —
Q3 2020
Shares 2,510 Value ($000) $38 Avg Close — Range —
Q2 2020
Shares 10,651 Value ($000) $271 Avg Close — Range —
Q1 2020
Shares 7,210 Value ($000) $112 Avg Close — Range —
Q4 2019
Shares 18,968 Value ($000) $210 Avg Close — Range —
Q3 2019
Shares 9,364 Value ($000) $80 Avg Close — Range —
Q2 2019
Shares 1,735 Value ($000) $23 Avg Close — Range —
Q3 2018
Shares 1,530 Value ($000) $39 Avg Close — Range —